Forecasted · Cooperative Agreement
Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
Centers for Disease Control and Prevention - ERA, Department of Health and Human Services
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
- Issuing agency
- Centers for Disease Control and Prevention - ERA (Department of Health and Human Services)
- Opportunity number
- RFA-IP-27-026
- Funding type
- Cooperative Agreement
- Funding purpose
- Health
- Status
- Forecasted
- Application deadline
- Forecasted · estimated close December 31, 2026 (agency estimate)Agency note: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
- Agency estimates
- Estimated posting: October 30, 2026. Estimated award date: August 31, 2027. Estimates can change.
- Published award range
- $1,350,000 – $3,550,000
- Estimated total program funding
- $75,250,000
- Expected number of awards
- 6
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 93.185
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/363343 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 363343 · Funding opportunity number RFA-IP-27-026
- Posted
- July 28, 2026 · Source last updated July 28, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 92% of key fields published by the sourceNot published: eligibility criteria text.
- Record confidence
- mediumforecast — dates and amounts are agency estimates.
Description (from the official listing)
The purpose of this notice of funding opportunity (NOFO) is to continue the work of the US Influenza Vaccine Effectiveness (Flu VE) Network. Influenza and other respiratory pathogens are important causes of morbidity, mortality, and healthcare burden across the age spectrum. This network provides evidence needed to improve the effectiveness of influenza and other respiratory pathogen vaccines. You would propose work under this NOFO to include: 1) annual VE and correlates of protection surveillance from active enrollment and systematic respiratory pathogen testing of outpatients; 2) electronic acute respiratory illness and VE surveillance; 3) household transmission research studies; and 4) immunogenicity research studies. This is a multi-component NOFO of Component A, B, C and D. The anticipated award number for each component is: five for Component A (VE and correlates of protection), one for Component B (Coordination and surge capacity), two for Component C (Household transmission studies) and three for Component D (Immunogenicity studies). You are required to apply for either Component A (VE and correlates of protection) or B (Coordination and surge capacity) but not both. If you apply for Component A, you may also apply for optional Components C (Household transmission studies) or D (Immunogenicity studies) or both. If you apply for Component B, you may also apply for optional Component D.We expect to fund 5 sites for Component A up to $1,800,000 per site annually and 1 site for Component B up to $1,800,000 annually. Up to 2 sites selected for Component A may be awarded…
Read the full description
The purpose of this notice of funding opportunity (NOFO) is to continue the work of the US Influenza Vaccine Effectiveness (Flu VE) Network. Influenza and other respiratory pathogens are important causes of morbidity, mortality, and healthcare burden across the age spectrum. This network provides evidence needed to improve the effectiveness of influenza and other respiratory pathogen vaccines. You would propose work under this NOFO to include: 1) annual VE and correlates of protection surveillance from active enrollment and systematic respiratory pathogen testing of outpatients; 2) electronic acute respiratory illness and VE surveillance; 3) household transmission research studies; and 4) immunogenicity research studies. This is a multi-component NOFO of Component A, B, C and D. The anticipated award number for each component is: five for Component A (VE and correlates of protection), one for Component B (Coordination and surge capacity), two for Component C (Household transmission studies) and three for Component D (Immunogenicity studies). You are required to apply for either Component A (VE and correlates of protection) or B (Coordination and surge capacity) but not both. If you apply for Component A, you may also apply for optional Components C (Household transmission studies) or D (Immunogenicity studies) or both. If you apply for Component B, you may also apply for optional Component D.We expect to fund 5 sites for Component A up to $1,800,000 per site annually and 1 site for Component B up to $1,800,000 annually. Up to 2 sites selected for Component A may be awarded optional Component C to be funded up to $1,00,000 per site annually. Up to 3 sites selected for either Components A or B may be awarded optional Component D to be funded up to $750,000 per site annually.
Agency contact
Jocelyn Patterson Mosley
jpatterson@cdc.gov